For any one familiar with RNA-Seq data from TCGA. Are there any control samples included in level3 data. From what I understand from the sample identifier (TCGA-06-0673-11) the last number 11 is for normal tissue and I can't find any samples for RNA-seq.
-
-
Hi Shahenda,
Yes there are a number of normal-adjacent samples available for the RNA-Seq. In fact, you can freely browse and analyze the RNA-SeqV2 (level 3) gene-level data in GenePool by taking advantage of the growing genomics reference library available to everyone. It also includes sample-level metadata curated by folks at Station X to make it easy to find the samples you are interested in analyzing.
Incidentally, we've also included the isoform-, splice-junction-, and exon-level counts in GenePool's premium content.
If you're interested in learning more, please check out GenePool's growing genomics library, check out the following threads:
Please feel free to contact us directly if you have any questions!
------------------------------
GenePool is making genomics data management, analysis, and sharing easier!
www.stationxinc.comLast edited by GenePool; 11-23-2014, 10:42 PM.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment